A Clinical Study of Herombopag in Tumors-associated Thrombocytopenia

NCT05350956 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Tumor Therapy-related Thrombocytopenia

Interventions

DRUG: TPO-RA (Herombopag)
DRUG: TPO-RA (Herombopag) and rhTPO(Recombinant human thrombopoietin)

Sponsor

The First Affiliated Hospital of Zhengzhou University

Collaborators

[object Object]